Next Article in Journal
Estimating Nitrogen Load Resulting from Biofuel Mandates
Next Article in Special Issue
Brazilian Green Propolis Improves Antioxidant Function in Patients with Type 2 Diabetes Mellitus
Previous Article in Journal
H-Type Hypertension and C Reactive Protein in Recurrence of Ischemic Stroke
Previous Article in Special Issue
Protective Action of Carica papaya on β-Cells in Streptozotocin-Induced Diabetic Rats
Article Menu

Export Article

Open AccessArticle
Int. J. Environ. Res. Public Health 2016, 13(5), 479; doi:10.3390/ijerph13050479

Hospitalisation Resulting from Medicine-Related Problems in Adult Patients with Cardiovascular Diseases and Diabetes in the United Kingdom and Saudi Arabia

1
Department of Pharmacy, Pharmacology and Postgraduate Medicine, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK
2
Medication Safety Research Chair, College of Pharmacy, King Saud University, Riyadh P.O. Box 2457, Saudi Arabia
*
Author to whom correspondence should be addressed.
Academic Editor: Omorogieva Ojo
Received: 28 February 2016 / Revised: 13 April 2016 / Accepted: 3 May 2016 / Published: 9 May 2016
(This article belongs to the Collection Health Care and Diabetes)
View Full-Text   |   Download PDF [289 KB, uploaded 9 May 2016]

Abstract

Cardiovascular diseases (CVDs) and diabetes (DM) are two interrelated conditions that have a heavy morbidity and mortality burden worldwide. Patients with the two conditions usually take multiple medicines and thus are more susceptible to medicine-related problems (MRPs). MRPs can occur at any stage of the treatment process and in many cases can lead to unplanned hospitalisations. The aim of the study was to determine the prevalence of hospitalisation resulting from MRPs in adult patients with CVDs and/or DM and to identify the main causes, risk factors, and medicine classes involved. A retrospective study included 300 adult patients from two hospitals, one in the United Kingdom and one in Saudi Arabia. To identify MRPs, medical records were reviewed for demographic data, clinical data, laboratory assay, and prescription records. A total of 197 (65.7%) patients had MRPs, of which less than 10% were severe. The main problems were lack of treatment effectiveness and adverse drug reactions. Moreover, polypharmacy and patient non-adherence were the main risk factors contributing to MRPs. The main medicine classes associated with MRPs were insulin and antihypertensive medicines. Further research should address the pharmaceutical care processes employed in treating CVDs and DM, and to empower patients/healthcare providers in tackling MRPs. View Full-Text
Keywords: cardiovascular diseases; diabetes; prevalence; medicine-related problems; hospitalisation; treatment effectiveness; adverse drug reactions; polypharmacy cardiovascular diseases; diabetes; prevalence; medicine-related problems; hospitalisation; treatment effectiveness; adverse drug reactions; polypharmacy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Al Hamid, A.; Aslanpour, Z.; Aljadhey, H.; Ghaleb, M. Hospitalisation Resulting from Medicine-Related Problems in Adult Patients with Cardiovascular Diseases and Diabetes in the United Kingdom and Saudi Arabia. Int. J. Environ. Res. Public Health 2016, 13, 479.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Environ. Res. Public Health EISSN 1660-4601 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top